About 1 results
Open links in new tab
Regeneron Reports Third Quarter 2025 Financial and Operating …
"We were pleased with our third quarter 2025 performance, which highlights the commercial strength of Dupixent, EYLEA HD, and Libtayo, and reinforces our momentum toward …